RP Bio lnc (XKRX:314140) Debt-to-Asset : 0.19 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is RP Bio lnc Debt-to-Asset?

RP Bio lnc's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩26,005 Mil. RP Bio lnc's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩4,616 Mil. RP Bio lnc's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was ₩163,051 Mil. RP Bio lnc's debt to asset for the quarter that ended in Mar. 2024 was 0.19.

RP Bio lnc Debt-to-Asset Historical Data

The historical data trend for RP Bio lnc's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RP Bio lnc Debt-to-Asset Chart

RP Bio lnc Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Debt-to-Asset

0.31

0.28

0.22

RP Bio lnc Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial						0.22	0.19	0.20	0.19	0.19

Competitive Comparison of RP Bio lnc's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, RP Bio lnc's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RP Bio lnc's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RP Bio lnc's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where RP Bio lnc's Debt-to-Asset falls into.

RP Bio lnc Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

RP Bio lnc's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(35549.916	+	2634.805)	/	173157.918
	=	0.22

RP Bio lnc's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(26004.604	+	4615.648)	/	163050.549
	=	0.19

RP Bio lnc (XKRX:314140) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

RP Bio lnc Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of RP Bio lnc's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

RP Bio lnc (XKRX:314140) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RP Bio lnc (XKRX:314140) » Definitions » Debt-to-Asset

Traded in Other Exchanges

N/A

Address

634, Samseong-ro, Gangnam-gu, Seoul, KOR, 06084

Website

http://www.rpskorea.com

RP Bio lnc is engaged in the pharmaceutical manufacturing business. It produces softgels, finished drugs, and other products.

RP Bio lnc (XKRX:314140) Headlines

No Headlines